SIRT1 Gene

gene · SciDEX wiki

Introduction

Pathway Diagram

flowchart TD
    SIRT1["SIRT1<br/>Sirtuin 1<br/>NAD+ dependent<br/>deacetylase"]
    
    AUTOPHAGY["Autophagy<br/>Pathway"]
    OXIDATIVE_STRESS["Oxidative<br/>Stress"]
    INFLAMMATION["Neuroinflammation"]
    AGING["Cellular<br/>Aging"]
    
    ALZHEIMER["Alzheimer's<br/>Disease"]
    PARKINSON["Parkinson's<br/>Disease"]
    ALS["Amyotrophic<br/>Lateral Sclerosis"]
    MS["Multiple<br/>Sclerosis"]
    
    NEUROPROTECTION["Neuroprotection"]
    MITOCHONDRIAL["Mitochondrial<br/>Function"]
    PROTEIN_AGGREGATION["Protein<br/>Aggregation"]
    NEURONAL_SURVIVAL["Neuronal<br/>Survival"]
    
    DNA_REPAIR["DNA Repair<br/>Mechanisms"]
    METABOLIC_REGULATION["Metabolic<br/>Regulation"]
    
    SIRT1 -->|"promotes"| AUTOPHAGY
    SIRT1 -->|"inhibits"| OXIDATIVE_STRESS
    SIRT1 -->|"protects against"| INFLAMMATION
    SIRT1 -->|"regulates"| AGING
    SIRT1 -->|"enhances"| MITOCHONDRIAL
    SIRT1 -->|"activates"| DNA_REPAIR
    SIRT1 -->|"controls"| METABOLIC_REGULATION
    
    AUTOPHAGY -->|"reduces"| PROTEIN_AGGREGATION
    AUTOPHAGY -->|"promotes"| NEURONAL_SURVIVAL
    
    OXIDATIVE_STRESS -->|"contributes to"| ALZHEIMER
    OXIDATIVE_STRESS -->|"contributes to"| PARKINSON
    PROTEIN_AGGREGATION -->|"leads to"| ALZHEIMER
    PROTEIN_AGGREGATION -->|"leads to"| ALS
    
    INFLAMMATION -->|"drives"| MS
    INFLAMMATION -->|"exacerbates"| PARKINSON
    
    MITOCHONDRIAL -->|"supports"| NEUROPROTECTION
    DNA_REPAIR -->|"maintains"| NEURONAL_SURVIVAL
    METABOLIC_REGULATION -->|"influences"| AGING
    
    SIRT1 -->|"therapeutic target"| ALZHEIMER
    SIRT1 -->|"therapeutic target"| ALS
    
    style SIRT1 fill:#006494
    style AUTOPHAGY fill:#1b5e20
    style NEUROPROTECTION fill:#1b5e20
    style MITOCHONDRIAL fill:#1b5e20
    style DNA_REPAIR fill:#1b5e20
    style NEURONAL_SURVIVAL fill:#1b5e20
    style OXIDATIVE_STRESS fill:#ef5350
    style INFLAMMATION fill:#ef5350
    style PROTEIN_AGGREGATION fill:#ef5350
    style METABOLIC_REGULATION fill:#4a1a6b
    style AGING fill:#4a1a6b
    style ALZHEIMER fill:#5d4400
    style PARKINSON fill:#5d4400
    style ALS fill:#5d4400
    style MS fill:#5d4400

Sirt1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

1(2006)2006 · Aging Cell · PMID 16905760Open reference
SIRT1
2(2002006)J Biol Chem · PMID 16469845Open reference
3(2018)2018 · Nat Rev Neurol · PMID 29559788Open reference **Full Name:** Sirtuin 1
4(2021)2021 · Mol Neurobiol · PMID 33788123Open reference **Chromosomal Location:** 10q21.3
**NCBI Gene ID:** 23411
**OMIM:** 604479
**Ensembl ID:** ENSG00000096717
**UniProt:** Q96EB6
**Associated Diseases:** Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Metabolic Syndrome

Overview

SIRT1 (Sirtuin 1) is a NAD+-dependent class III histone deacetylase that catalyzes the removal of acetyl groups from lysine residues on histones and various regulatory proteins. As a master regulator of cellular stress responses, metabolism, and aging, SIRT1 has emerged as a critical protective factor in neurodegenerative diseases. SIRT1 activation promotes longevity and neuroprotection through multiple downstream targets including PGC-1α, FOXO, p53, and NF-κB.

Function

SIRT1 uses NAD+ as a cofactor, linking its activity to cellular energy status and metabolic health. The enzyme deacetylates both histones (H3K9, H3K14, H4K16) and non-histone proteins, thereby regulating gene expression and protein function.

Key functions include:

  • Chromatin Regulation: Deacetylates histones to promote heterochromatin formation and silence repetitive elements

  • Metabolic Regulation: Activates PGC-1α for mitochondrial biogenesis

  • Stress Response: Deacetylates FOXO transcription factors to enhance antioxidant gene expression

  • Inflammation: Inhibits NF-κB signaling through deacetylation

  • Protein Quality Control: Promotes autophagy and proteasomal degradation

  • DNA Repair: Facilitates DNA damage repair through histone deacetylation

Disease Associations

Alzheimer’s Disease

SIRT1 is protective in AD through multiple mechanisms:

  • Deacetylates tau and reduces its aggregation

  • Activates alpha-secretase (ADAM10) to promote non-amyloidogenic APP processing

  • Reduces Aβ-induced neurotoxicity

  • Anti-inflammatory effects through NF-κB inhibition

  • Promotes mitochondrial function and reduces oxidative stress SIRT1 levels are decreased in AD brain, and resveratrol treatment shows promise in clinical trials.

Parkinson’s Disease

SIRT1 protects dopaminergic neurons through:

  • Mitochondrial biogenesis via PGC-1α activation

  • Reduction of alpha-synuclein aggregation

  • Protection against 6-OHDA and MPTP toxicity

  • Enhancement of autophagy to clear damaged proteins

  • Anti-apoptotic effects through FOXO activation

Sirtuin Pathway Dysfunction in PD

The Sirtuin Pathway Dysfunction Hypothesis in Parkinson’s Disease proposes that SIRT1 dysfunction is a primary driver of dopaminergic neurodegeneration. Key connections include:

  1. NAD+ decline: SIRT1 requires NAD+ as a cofactor. Age-related NAD+ decline directly impairs SIRT1 activity in dopaminergic neurons. PMID: 31740891

  2. FOXO3a dysregulation: SIRT1-mediated deacetylation activates FOXO3a, promoting antioxidant gene expression (MnSOD, catalase). In PD, reduced SIRT1 leads to FOXO3a hyperacetylation and impaired stress response. PMID: 29550616

  3. PGC-1α dysfunction: SIRT1 deacetylates PGC-1α, the master regulator of mitochondrial biogenesis. SIRT1 dysfunction contributes to the well-documented mitochondrial deficiency in PD dopaminergic neurons.

  4. Autophagy impairment: SIRT1 promotes autophagy through deacetylation of autophagy proteins (LC3, Beclin-1). Impaired SIRT1 reduces clearance of misfolded alpha-synuclein, contributing to aggregation.

Clinical Evidence for SIRT1 in PD

Finding Study PMID
SIRT1 activity reduced in PD patient-derived neurons Tyrrell et al. 30659479
SIRT1 rs7895833 A allele increases PD risk Liu et al. 29550616
SRT2104 (SIRT1 activator) protects in MPTP model -- --

SIRT1 in the NADAPT Study

The NADAPT Study (NCT06162013) evaluates NAD+ precursor supplementation, which indirectly increases SIRT1 activity by providing more substrate (NAD+). This provides a therapeutic approach to address SIRT1 dysfunction in PD.

See the Sirtuin Pathway Dysfunction Validation Experiment for detailed study design.

Huntington’s Disease

SIRT1 activity is beneficial in HD:

  • Mutant huntingtin protein causes SIRT1 dysregulation

  • SIRT1 activation reduces mHTT toxicity in models

  • PGC-1α activation compensates for mitochondrial dysfunction

  • Deacetylates huntingtin to promote clearance

  • Resveratrol and other SIRT1 activators show preclinical promise

Expression

SIRT1 is widely expressed in the brain with high levels in:

SIRT1 expression decreases with age and in neurodegenerative diseases.

Key Publications

  1. “SIRT1 deacetylase protects against neurodegeneration” - Nature (2009) - DOI:10.1038/nature08542

  2. “SIRT1 and Alzheimer’s disease: role in pathogenesis and therapy” - Journal of Alzheimer’s Disease (2020) - DOI:10.3233/JAD-190917

  3. “Resveratrol and SIRT1 activation in Parkinson’s disease” - Movement Disorders (2019) - DOI:10.1002/mds.27766

  4. “NAD+ and SIRT1 in age-related neurodegeneration” - Cell Metabolism (2021) - DOI:10.1016/j.cmet.2021.06.020

  5. “SIRT1 activation as a therapeutic strategy for Huntington’s disease” - Brain (2018) - DOI:10.1093/brain/awy115

Therapeutic Targeting

Agent Mechanism Development Stage Notes
Resveratrol SIRT1 activator Phase II/III Natural compound, limited bioavailability
SRT1720 SIRT1 selective activator Preclinical 1000x potency vs resveratrol
SRT2104 SIRT1 selective activator Phase I Good brain penetration
NAD+ precursors SIRT1 substrate Phase II NR, NMN increase SIRT1 activity
Piceatannol SIRT1 activator Preclinical Analog of resveratrol

Background

The study of Sirt1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

Allen Brain Atlas Resources

References

  1. (2006) Haigis MC et al 2006 · Aging Cell · PMID 16905760
  2. (2002006) Qin W et al J Biol Chem · PMID 16469845
  3. (2018) Min SW et al 2018 · Nat Rev Neurol · PMID 29559788
  4. (2021) Jesus M et al 2021 · Mol Neurobiol · PMID 33788123

Sister wikis (recently updated · no domain on this page)

Recent activity here

No recent events touching this page.

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.

for agents scidex.get

Fetch the full wiki article for this entity — markdown body, citations, linked artifacts, sister pages, and recent activity. Follow-up verbs: scidex.comment (add comment), scidex.signal (vote/fund/bet), scidex.link (create artifact link), scidex.list (navigate related wiki pages).

POST /api/scidex/rpc
{
  "verb": "scidex.get",
  "args": {
    "ref": "wiki_page:genes-sirt1"
  }
}